Remove Bioinformatics Remove Organic Chemistry Remove Science
article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Enkelejda Miho, PhD, Professor, University of Applied Sciences and Arts Northwestern Switzerland, and Managing Director, aiNET, on: ‘The singular immune response to dengue and machine learning identification of antibodies in high-throughput sequences’.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Rising from Research Scientist to Senior Scientist, I supported early-stage DD efforts within their Protein Science group, based in Cambridge, UK.

article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Kathrin Herbst, PhD, Director of Science & Business Development, Lightcast, on: ‘A new era of single-cell functional profiling for drug discovery’. David Mills, PhD, Senior Director, Preclinical Science, Ambrx, on: ‘Preclinical discovery of ARX622, a site-specific HER2-targeted TLR7 agonist immune-stimulatory antibody conjugate’.